CALL US

News

Holiday IRB Meeting Schedule – Labor Day

Due to the upcoming Labor Day holiday, some submission deadlines and IRB meeting dates have been modified.

READ MORE

ACRP Features Dr. Daniel Eisenman in Gene Therapy Research Article

Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP, discusses the rise in risks and opportunities for gene therapy research in a recent ACRP article.

READ MORE

Schulman IRB’s Director of Biosafety Services to Present ACRP Webinar

Schulman IRB’s Director of Biosafety Services, Daniel Eisenman, will be presenting ACRP webinar on the current state of gene therapy.

READ MORE

Updated Processes to Accommodate New FDA Guidance on Waivers of Consent

Schulman IRB has updated submission and review processes to accommodate FDA’s new guidance document IRB Waiver or Alteration of Informed Consent for Clinical Investigations Involving No More Than Minimal Risk to Human Subjects. Intended for immediate implementation, this guidance explains that FDA “does not intend to object to an IRB waiving or altering informed consent […]

READ MORE

Updated Submission Forms Now Available

Schulman has revised many of its submission forms to accommodate electronic informed consent (eIC) submissions, make it easier for sponsors/CROs to approve revisions to site changes, and provide further clarification to information needed for review.

READ MORE

Michele Russell-Einhorn Named to 2017 PharmaVOICE 100 Most Inspiring People

Michele Russell-Einhorn, JD, Vice President of Human Research Protection Services and Institutional Official, was named to the 2017 PharmaVOICE 100 list.

READ MORE

Schulman IRB Launches Central Neurology Review (CNR) Service

Schulman IRB, the industry-leading central IRB in customer service and technology, is pleased to announce the formal launch of its Central Neurology Review (CNR) service. Through its partnership with the National Biomedical Research Ethics Council (NBREC), a Nevada-based 501(c) non-profit, Schulman developed CNR to assist research institutions and biopharma and device companies in navigating the […]

READ MORE

Updated Processes for eConsent

Schulman IRB has updated and improved its review processes and policies for studies utilizing electronic consent (eConsent or eIC). Given the evolving nature of eConsent technology and the increasing use of eConsent in clinical research, Schulman’s IRB and operational staff have examined processes and implemented improvements to ensure it continues to deliver services that meet […]

READ MORE